Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1

Neurology

Volumn 60, Issue 7, 2003, Pages 1139-1145

  Hyman, S L ^a,b   Gill, D S ^a   Shores, E A ^c   Steinberg, A ^a   Joy, P ^a   Gibikote, S V ^a   North, K N ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CHILDHOOD; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; EQUIPMENT; FEMALE; HUMAN; INTELLECT; LONGITUDINAL STUDY; MALE; NEUROFIBROMATOSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER;

EID: 0037426390     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000055090.78351.C1     Document Type: Article

References (43)

1. North KN, Riccardi V, Samango-Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 cognitive disorders task force. Neurology 1997;48:1121-1127.
2. Riccardi VM, Eichner JE. Neurofibromatosis. Phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press, 1986.
3. Zoeller MET, Rembeck B, Baeckman L. Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Scand 1997;95:225-232.
4. Ferner RE, Hughes RAC, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996;138:25-133.
5. Sevick RJ, Barkovich AJ, Edwards MSB, et al. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Radiol 1992;159:171-175.
6. Ferner RE, Chaudhuri R, Bingham J, et al. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56:492-495.
7. Itoh T, Magnaldi S, White RM, et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. Am J Neuroradiol 1994;15:1513-1519.
8. Van Es S, North KN, McHugh K, de Silva M. MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 1996;26:478-487.
9. DiPaolo DP, Zimmerman RA, Rorke LB, et al. Neurofibromatosis type 1: pathologic substrate of high-signal intensity foci in the brain. Radiology 1995;195:721-724.
10. North K, Joy P, Yuille D, et al. Learning difficulties in neurofibromatosis 1: the significance of MRI abnormalities. Neurology 1994;44:878-883.
11. Joy P, Roberts C, North K, De Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995;37:906-914.
12. Samango-Sprouse C. Frontal lobe development in childhood. In: Miller BL, Cummings JL, eds. The human frontal lobes: functions and disorders. The science and practice of neuropsychology series. New York: The Guilford Press, 1999;584-603.
13. Denckla MD, Hofman K, Mazzocco MMM, et al. Relationship between T2H-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102.
14. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy B. Neuropsychological significance of areas of high signal intensity on brain magnetic resonance imaging scans of children with neurofibromatosis. Neurology 1996;46:1660-1668.
15. DiMario FJ, Ramsby G, Greenstein R, Langshur S, Dunham B. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol 1993;8:32-39.
16. National Institute of Health Consensus Development Conference. Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.
17. Wechsler D. Wechsler Intelligence Scale for Children - Revised. New York: The Psychological Corporation, 1981.
18. Wechsler D. Wechsler Adult Intelligence Scale - 3rd edition. New York: Psychological Corporation, 1997.
19. Wechsler D. Wechsler Intelligence Scale for Children - 3rd edition. New York: Psychological Corporation, 1991.
20. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
21. Sheslow D, Adams W. Wide range assessment of memory and learning. Wilmington: Jastak Associates, 1990.
22. Buschke H. Selective reminding analysis of memory and learning. J Verb Behav 1973;12:543-550.
23. Meyers JE, Meyers KR. Rey Complex Figure Test and Recognition Trial. Odessa, FL: Psychological Assessment Resources, 1995.
24. Benton A, Varney N, Hamsher K. Judgement of Line Orientation. Iowa City: Department of Neurology, University of Iowa, 1976.
25. Benton A, Stone FB. Benton Visual Retention Test - Multiple Choice Form. Iowa City: Department of Neurology, University of Iowa, 1970.
26. Heaton K. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources, 1981.
27. Spreen O, Strauss EA. Compendium of neuropsychological tests: administration, norms, and commentary, 2nd ed. New York: Oxford University Press, 1997.
28. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test - Revised. Circle Pines, MN: American Guidance Service, 1981.
29. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test - 3rd edition. Minnesota: American Guidance Service, 1993.
30. Beery K. The Developmental Test of Visual-Motor Integration; administration, scoring and teaching manual. Third revision. Cleveland: Modern Curriculum Press, 1989.
31. Beery K. The Developmental Test of Visual-Motor Integration - 4th edition. Cleveland: Modern Curriculum Press, 1997.
32. Stott D, Moyes F, Henderson S. Test of Motor Impairment: Henderson revision. Ontario: Brook Educational, 1984.
33. Trites R. Grooved Pegboard Instruction Manual. Lafayette, IN: Lafayette Instrument, 1989.
34. Elliot CD. Differential Ability Scales. New York: Psychological Corporation, 1990.
35. Wilkinson G. The Wide Range Achievement Test. Wilmington, DE: Wide Range, 1993.
36. Wechsler D. WAIS-III - WMS-III technical manual. New York: Psychological Corporation, 1997.
37. Neisser U. The rising curve: long-term gains in IQ and related measures. Washington, DC: American Psychological Association, 1998.
38. Dilts CV, Carey JC, Kircher JC, et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr 1996;17:229-239.
39. Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr 1994;124:S1-S8.
40. Mott S, Kkryja PB, Baumgardner T, et al. Neurofibromatosis type I (NF1): association between volumes of T2H-weighted high intensity signals (UBOs) on magnetic resonance imaging (MRI) and impaired performance on the Judgement of Line Orientation (JLO). Presented at the conjoint meeting of the CNS and ICNA; San Francisco, CA; October 2-8, 1994.
41. Moore BD III, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000;54:914-920.
42. Kayl AE, Moore BD III, Slopis JM, Jackson EF, Leeds NE. Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 2000;15:90-96.
43. Said SMA, Yeh T, Greenwood RS, et al. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport 1996;7:1941-1944.